Glycos Biotechnologies
Glycos Biotechnologies: Global provider of bio-chemical products and services using biotechnology.
Founded
2007Glycos Biotechnologies: Global provider of bio-chemical products and services using biotechnology.
Glycos Biotechnologies, founded with a mission to harness the power of biotechnology for creating innovative bio-chemical products, focuses on improving therapeutic outcomes through advanced lipid engineering. The company offers a range of products including palm acids, carbohydrates, crude butylene concentration stream, ethylene, propylene, and synthetic rubber. Their market focus spans globally, serving diverse industries with a commitment to enhancing the therapeutic performance of natural bioactive molecules.
Notable figures affiliated with Glycos Biotechnologies include leading scientists and industry experts in enzymology and lipid engineering. The company has achieved significant milestones in developing a library of Activated Oil Systems, which unlock novel therapeutic benefits for patients. Glycos Biotechnologies has made a substantial impact on the life sciences sector by advancing research in lipid engineering, microbiota influence, and bioavailability, contributing to the development of prospective therapies for conditions like dysbiosis.
Companies similar to Glycos Biotechnologies include Glycan Therapeutics, Glycologix, NatGlycan and Glycomine.
Glycos Biotechnologies was founded in 2007.
Glycos Biotechnologies' headquarters is located in Houston, TX, US.
Glycos Biotechnologies' most recent funding round was for $425k (USD) in April 2023.
As of Apr 6, 2023, Glycos Biotechnologies has raised a total of $19.8M (USD).
Glycos Biotechnologies has 35 employees as of Feb 5, 2024.
NatGlycan
